Cathie Wood’s ARK Invest Buys Over 380,000 Shares of Pfizer
One of Cathie Wood's ARK Invest exchange-traded funds bought over 380,000 shares of Pfizer on September 1.
One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 380,000 shares of Pfizer Inc. (NYSE: PFE | PFE Price Prediction) on Wednesday, as the price of this fund was up over 1% in the day’s session. It is also up a fair amount in the past year.
ARK Genomic Revolution ETF (NYSEARCA: ARKG) added 382,231 shares of Pfizer. At Wednesday’s closing price, this would have valued this purchase at roughly $17.6 million. This is only a small fraction of the total holdings. The fund is up about 42% over the past 52 weeks.
Check out all the ARK Invest buys for Wednesday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | TDOC | TELADOC HEALTH | 16,089 |
| ARKF | Z | ZILLOW | 2,688 |
| ARKG | RPTX | REPARE THERAPEUTICS | 3,200 |
| ARKG | PSNL | PERSONALIS | 3,781 |
| ARKG | PFE | PFIZER | 382,231 |
| ARKG | NVTA | INVITAE | 12,514 |
| ARKG | ADPT | ADAPTIVE BIOTECHNOLOGIES | 800 |
| ARKK | FATE | FATE THERAPEUTICS | 1,075 |
| ARKK | SGFY | SIGNIFY HEALTH | 189,960 |
| ARKQ | ACIC | ATLAS CREST INVESTMENT | 144,000 |
| ARKQ | BLDE | BLADE AIR MOBILITY | 36,482 |
| ARKQ | SPFR | JAWS SPITFIRE ACQUISITION | 14,879 |
| ARKQ | KMTUY | KOMATSU | 103,400 |
| ARKQ | KTOS | KRATOS DEFENSE & SECURITY SOLUTIONS | 41,408 |
| ARKQ | MKFG | MARKFORGED | 56,216 |
| ARKW | GENI | GENIUS SPORTS | 121,401 |
| ARKX | 6301JP | KOMATSU | 62,800 |
| ARKX | ACIC | ATLAS CREST INVESTMENT | 31,000 |
| ARKX | PRNT | 3D PRINTING ETF | 8,903 |
[nativounit]
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St.
[recirclink id=945344][wallst_email_signup]
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
